i. Mankind Pharma is India’s fourth largest pharmaceutical company in terms of Domestic Sales and second largest in terms of sales volume for the Financial Year 2022.

ii. The company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.

iii. They have created 36 brands in its pharmaceutical business that have each achieved over ₹500.00 million in Domestic Sales in the Financial Year 2022.

iv. They are present in several acute and chronic therapeutic areas in India, including anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins/minerals/nutrients and respiratory. Mankind Covered Market presence in the IPM has increased from approximately 62% to approximately 64% between the Financial Years 2020 and 2022v

v. Mankind entered the consumer healthcare industry in 2007 and have since established several differentiated brands in the condoms, pregnancy detection, emergency contraceptives, antacid powders, vitamin and mineral supplements and anti-acne preparations categories. Their total Covered Market for its consumer healthcare business amounted to ₹203.60 billion for the Financial Year 2022

vi. The company has a pan-India marketing presence, with a field force of 11,196 medical representatives and 3,195 field managers, as of March 31, 2022. They have also established a significant distribution network in India and, during the Financial Year 2022, the company sold its products to over 11,000 stockists and engaged with 75 clearing and forwarding (“C&F”) agents.

vii. They operate 23 manufacturing facilities across India and had 2,181 manufacturing personnel.

Competitive Strengths

i. Scaled domestic-focused business with potential for further growth
ii. Growing faster than the rate of the IPM with a focus on volume-led growth
iii. Established and growing consumer healthcare franchise with brand recall